N. Lugering et al., MONOCLONAL-ANTIBODY 1F10 IMMUNOREACTIVITY IN INFLAMMATORY BOWEL-DISEASE - A NEW MARKER SPECIFIC ONLY FOR CONTINUOUS ENDOTHELIAL-CELLS, European journal of gastroenterology & hepatology, 7(8), 1995, pp. 777-781
Objective: To investigate in detail the immunohistochemical properties
of the two endothelial-specific markers 1F10 (continuous endothelia)
and MS-1 (discontinuous endothelia) in bowel tissues of patients suffe
ring from chronic inflammatory bowel disease (IBD). Method: Immunohist
ochemical techniques were employed to study the morphology and phenoty
pic expression of these two proteins in routinely processed bower tiss
ues from 27 patients with Crohn's disease, 18 patients with ulcerative
colitis, and 20 normal controls. Results: All patients with IBD and c
ontrols showed a low to moderate 1F10 immunohistochemical staining res
tricted to the lamina propria and submucosa. In contrast to ulcerative
colitis patients and healthy controls, 1F10 immunoreactivity was stro
ngly upregulated in the muscularis propria of the small and large bowe
r in Crohn's disease patients regardless of the histological severity
of the inflammatory process. We did not observe immunoreactivity for M
S-1 on endothelial surfaces in either Crohn's disease or ulcerative co
litis. Conclusions: We conclude that endothelia in patients with IBD d
o not undergo metaplasia. The high immunoreactivity of 1F10 antigen in
the muscularis propria in Crohn's disease indicates a state of topica
l immunological activation and may be important in the maintenance of
chronic inflammation by facilitating leukocyte migration into sites of
Crohn's disease involvement. Further studies of the factors controlli
ng endothelial cell differentiation in the bowel of Crohn's disease pa
tients may help to explain the features observed in this study.